P1219: zanubrutinib, lenalidomide plus r-chop (zr2-chop) as the first-line treatment for non-gcb diffused large b-cell lymphoma (dlbcl)

H. Zhu,Y. Sha, Y. Miao, S. Qin,W. Wu,J. Qiu, H. Mi,Y. Yang,C. Peng,C. Ding,Z. Wang, L. Fan, W. Xu, J. Li

HemaSphere(2022)

引用 0|浏览7
暂无评分
关键词
lymphoma,zanubrutinib,dlbcl,lenalidomide,r-chop,first-line,non-gcb,b-cell
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要